Media Resources

Media Resources

Recent News
Date Title
Jul 27, 2021
GBT to Announce Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
Jul 22, 2021
GBT Provides Regulatory and Pipeline Updates in Sickle Cell Disease (SCD)
Jul 09, 2021
GBT Announces New Employment Inducement Grants
Jun 15, 2021
GBT Awards $450,000 in ACCEL Grants to Improve Access to Care in Sickle Cell Disease
Jun 14, 2021
GBT’s Voxelotor is First Sickle Cell Disease Treatment to Receive Promising Innovative Medicine (PIM) Designation in the UK
Media Resources

Media and Investor Contact

Steven Immergut
SVP, Head of Corporate Communications and Investor Relations
650-410-3258
simmergut@gbt.com